Sex Differences in Dermatology Life Quality Index (DLQI) among Patients with Psoriasis
DOI:
https://doi.org/10.2340/actadv.v104.42441Keywords:
psoriasis, biologics, QoL, PASI, DLQIDownloads
References
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
https://doi.org/10.1136/bmj.m1590 DOI: https://doi.org/10.1136/bmj.m1590
Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 123-125.
https://doi.org/10.1046/j.1365-2133.2002.04742.x DOI: https://doi.org/10.1046/j.1365-2133.2002.04742.x
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 123-125.
https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Zou Q, Luo Y, Hao D, Li M, Jihui C, et al. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients. J Health Popul Nutr 2024; 43: 92.
https://doi.org/10.1186/s41043-024-00587-3 DOI: https://doi.org/10.1186/s41043-024-00587-3
Maul JT, Maul LW, Didaskalu JA, Valenzuela F, Romiti R, Peterson H, et al. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in patients with psoriasis: a cross-sectional global healthcare study on psoriasis. Acta Derm Venereol 2024; 104: adv20329.
https://doi.org/10.2340/actadv.v104.20329 DOI: https://doi.org/10.2340/actadv.v104.20329
Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D, et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006; 154: 123-125.
https://doi.org/10.1111/j.1365-2133.2005.06909.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06909.x
Böhm D, Stock Gissendanner S, Bangemann K, Snitjer I, Werfel T, Weyergraf A, et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol 2013; 27: 123-125.
https://doi.org/10.1111/j.1468-3083.2012.04451.x DOI: https://doi.org/10.1111/j.1468-3083.2012.04451.x
Maul JT, Augustin M, Sorbe C, Conrad C, Anzengruber F, Mrowietz U, et al. Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study. Br J Dermatol 2021; 185: 123-125.
https://doi.org/10.1111/bjd.20387 DOI: https://doi.org/10.1111/bjd.20387
Mabuchi T, Yamaoka H, Kojima T, Ikoma N, Akasaka E, Ozawa A, et al. Psoriasis affects patient's quality of life more seriously in female than in male in Japan. Tokai J Exp Clin Med 2012; 37: 123-125.
Loft ND, Egeberg A, Rasmussen MK, Bryld LE, Gniadecki R, Dam TN, et al. Patient-reported outcomes during treatment in patients with moderate-to-severe psoriasis: A Danish nationwide study. Acta Derm Venereol 2019; 99: 123-125.
https://doi.org/10.2340/00015555-3331 DOI: https://doi.org/10.2340/00015555-3331
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Mikkel Bak Jensen, Nikolai Loft, Claus Zacheriae, Lone Skov

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.